PAMS
RETA

Pictet Asset Management (Switzerland)’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		$270K Sell
2,646
-558
-17% -$56.9K ﹤0.01% 1565
2023
Q1 		$291K Buy
+3,204
New +$291K ﹤0.01% 1498
2021
Q4 		– Sell
-98,616
Closed -$9.92M – 1812
2021
Q3 		$9.92M Buy
+98,616
New +$9.92M 0.01% 662